Inhibition of monoterpene cyclases by sulfonium analogs of presumptive carbocationic intermediates of the cyclization reaction.
The enzymatic cyclization of geranyl pyrophosphate to monoterpenes is thought to proceed through a series of carbocation-pyrophosphate anion paired intermediates. Sulfonium analogs of two putative carbocationic intermediates of the cyclization sequence were shown to be inhibitors of the conversion of the acyclic precursor to the bicyclic monoterpenes (+)-alpha-pinene and (+)-bornyl pyrophosphate by partially purified cyclase preparations from sage (Salvia officinalis). The sulfonium analog of the tertiary allylic, linalyl, intermediate (i.e. methyl-(4-methylpent-3-en-1-yl)vinyl-sulfonium perchlorate) provided respective Ki values of 2.5 microM and 3.0 microM against the cyclization to alpha-pinene and bornyl pyrophosphate at a substrate concentration of 5 microM, whereas the sulfonium analog of the monocyclic, alpha-terpinyl, intermediate (i.e. dimethyl-(4-methylcyclohex-3-en-1-yl) sulfonium iodide) exhibited respective Ki values of 3.4 microM and 3.9 microM against the same two cyclizations. The potency of inhibition in all cases increased with increasing substrate concentration, indicating that the affinity of the enzymes for the sulfonium analogs was increased by the presence of the pyrophosphate ester. Inorganic pyrophosphate at a concentration of 50 microM, which alone had little influence on the cyclizations, increased the effectiveness of inhibition of the sulfonium analogs severalfold, and the apparent Ki for inorganic pyrophosphate was reduced manyfold by the presence of either analog at 5 microM. That the combination of sulfonium analog and pyrophosphate provided synergistic inhibition of the electrophilic cyclizations indicated that the cyclases bind the paired species more tightly than either partner alone. Specificity studies suggested that inhibition by the above sulfonium ion:pyrophosphate pairs was due to both electronic and structural resemblance to intermediates of the reaction.
D000476:Alkanesulfonates / Q000494:pharmacology; D017738:Alkanesulfonic Acids; D003500:Cyclization; D011756:Diphosphates / Q000494:pharmacology; D019753:Intramolecular Lyases; D007535:Isomerases / Q000037:antagonists & inhibitors*; D007700:Kinetics; D009025:Morpholines / Q000494:pharmacology; D009861:Onium Compounds / Q000494:pharmacology*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013452:Sulfonium Compounds / Q000494:pharmacology*; D013729:Terpenes / Q000378:metabolism*
D000476:Alkanesulfonates; D017738:Alkanesulfonic Acids; D011756:Diphosphates; D009025:Morpholines; D009861:Onium Compounds; D013452:Sulfonium Compounds; D013729:Terpenes; C004550:2-(N-morpholino)ethanesulfonic acid; D007535:Isomerases; D019753:Intramolecular Lyases; C040265:pinene cyclase I; C044526:geranyl-diphosphate cyclase